Riham Katkhuda

980 total citations
15 papers, 197 citations indexed

About

Riham Katkhuda is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Riham Katkhuda has authored 15 papers receiving a total of 197 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Riham Katkhuda's work include Colorectal Cancer Treatments and Studies (8 papers), Gastric Cancer Management and Outcomes (4 papers) and Cancer Genomics and Diagnostics (3 papers). Riham Katkhuda is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Gastric Cancer Management and Outcomes (4 papers) and Cancer Genomics and Diagnostics (3 papers). Riham Katkhuda collaborates with scholars based in United States, Taiwan and Syria. Riham Katkhuda's co-authors include Dipen M. Maru, Scott Kopetz, Michael J. Overman, David G. Menter, Jonathan M. Loree, Jeffrey S. Morris, Andrea Murányi, Marwan Fakih, Mark J. Routbort and Funda Meric‐Bernstam and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Riham Katkhuda

14 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Riham Katkhuda United States 6 150 68 65 42 41 15 197
Effie Skrinos Australia 4 109 0.7× 35 0.5× 55 0.8× 43 1.0× 21 0.5× 8 151
Rossana Intini Italy 9 233 1.6× 69 1.0× 82 1.3× 59 1.4× 63 1.5× 29 307
Maria Bensi Italy 8 180 1.2× 81 1.2× 58 0.9× 54 1.3× 58 1.4× 33 245
Akane Naruoka Japan 8 88 0.6× 66 1.0× 63 1.0× 41 1.0× 96 2.3× 20 190
Zhao-Li Tan China 7 127 0.8× 35 0.5× 42 0.6× 61 1.5× 69 1.7× 17 186
Xiaohong Yan United States 6 193 1.3× 35 0.5× 84 1.3× 83 2.0× 85 2.1× 7 260
Kanwal Pratap Singh Raghav United States 5 163 1.1× 68 1.0× 117 1.8× 19 0.5× 41 1.0× 8 245
Giovanni Burrafato Italy 9 157 1.0× 35 0.5× 139 2.1× 64 1.5× 96 2.3× 13 247
Keitaro Shimozaki Japan 10 191 1.3× 39 0.6× 115 1.8× 14 0.3× 31 0.8× 33 257
Silvana Acquafredda Italy 6 159 1.1× 22 0.3× 94 1.4× 42 1.0× 40 1.0× 8 237

Countries citing papers authored by Riham Katkhuda

Since Specialization
Citations

This map shows the geographic impact of Riham Katkhuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riham Katkhuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riham Katkhuda more than expected).

Fields of papers citing papers by Riham Katkhuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riham Katkhuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riham Katkhuda. The network helps show where Riham Katkhuda may publish in the future.

Co-authorship network of co-authors of Riham Katkhuda

This figure shows the co-authorship network connecting the top 25 collaborators of Riham Katkhuda. A scholar is included among the top collaborators of Riham Katkhuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riham Katkhuda. Riham Katkhuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Maki, Harufumi, Anuj Verma, Riham Katkhuda, et al.. (2024). New insights into macrophage polarization and its prognostic role in patients with colorectal cancer liver metastasis. PubMed. 2(1). 37–37.
2.
Omran, Mervat M., et al.. (2024). Exosome Therapy: A Novel Approach for Enhancing Estrogen Levels in Perimenopause. International Journal of Molecular Sciences. 25(13). 7075–7075. 5 indexed citations
3.
Goltsov, Alexei A., Dipen M. Maru, Riham Katkhuda, et al.. (2023). ANPEP/CD13 Expression as a Marker of Lymphovascular Invasion and Survival in Esophageal Adenocarcinoma. The Annals of Thoracic Surgery. 118(1). 241–251. 1 indexed citations
4.
Nusrat, Maliha, Riham Katkhuda, Edwin R. Parra, et al.. (2022). The immune impact of PI3K-AKT pathway inhibition in colorectal cancer.. Journal of Clinical Oncology. 40(4_suppl). 154–154. 1 indexed citations
5.
Chun, Yun Shin, Guillaume Passot, Yujiro Nishioka, et al.. (2022). Colorectal Liver Micrometastases: Association with RAS/TP53 Co-Mutation and Prognosis after Surgery. Journal of the American College of Surgeons. 235(1). 8–16. 8 indexed citations
6.
Sarshekeh, Amir Mehrvarz, Jason Roszik, Ganiraju C. Manyam, et al.. (2021). ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer. Clinical Cancer Research. 27(6). 1663–1670. 40 indexed citations
7.
Lam, Michael, Preeti Kanikarla Marie, Amir Mehrvarz Sarshekeh, et al.. (2020). Consensus molecular subtypes (CMS) as a marker for treatment and disease biology in metastatic colorectal cancer (CRC).. Journal of Clinical Oncology. 38(15_suppl). 4089–4089. 2 indexed citations
8.
Nusrat, Maliha, Jason Roszik, Riham Katkhuda, et al.. (2019). Association of PIK3CA mutations (mut) with immune engagement and clinical benefit from immunotherapy in microsatellite stable (MSS) colorectal cancer (CRC) patients (pts).. Journal of Clinical Oncology. 37(15_suppl). 3604–3604. 13 indexed citations
9.
Raghav, Kanwal Pratap Singh, Jonathan M. Loree, Jeffrey S. Morris, et al.. (2019). Validation of HER2 Amplification as a Predictive Biomarker for Anti–Epidermal Growth Factor Receptor Antibody Therapy in Metastatic Colorectal Cancer. JCO Precision Oncology. 3(3). 1–13. 93 indexed citations
10.
Nelson, David B., Rajeev Dhupar, Riham Katkhuda, et al.. (2018). Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery. 156(1). 406–413.e3. 19 indexed citations
11.
Nusrat, Maliha, Jason Roszik, Riham Katkhuda, et al.. (2018). Association of phosphatidylinositol 3-kinase (PI3K) pathway activation with increased immune checkpoint expression in colorectal cancer (CRC) patients.. Journal of Clinical Oncology. 36(4_suppl). 653–653. 5 indexed citations
12.
Tong, Zhimin, Jianhu Zhang, Yawei Qiao, et al.. (2017). Targeting cyclin-dependent kinase 9 enhances sensitization to ionizing radiation in esophageal adenocarcinoma and identifies AXL as a novel downstream target. European Journal of Surgical Oncology. 43(11). 2222–2222. 1 indexed citations
13.
Reilley, Matthew J., Sreyashi Basu, Riham Katkhuda, et al.. (2017). Prognostic implications of TAMs in colorectal cancer hepatic metastases.. Journal of Clinical Oncology. 35(15_suppl). 3574–3574. 3 indexed citations
14.
Korphaisarn, Krittiya, Chao‐Kai Chou, Wei Xia, et al.. (2017). Arginine methylation of EGFR: a new biomarker for predicting resistance to anti-EGFR treatment.. PubMed. 7(12). 2587–2599. 2 indexed citations
15.
Reilley, Matthew J., Jorge Blando, Riham Katkhuda, et al.. (2016). Immunologic profiling of consensus molecular subtype (CMS) stratified colorectal cancer (CRC) primary and liver metastectomy specimens: Implications for immune targeting of proficient mismatch repair CRC.. Journal of Clinical Oncology. 34(15_suppl). 3520–3520. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026